Copay Assistance Programs Help Patients but Confuse Them Too https://t.co/WuPkwrE3ZF

• https://bit.ly/38SnDFq

Type I interferon (IFN1) produced by plasmacytoid dendritic cells are prime drivers of adaptive immunity. Study of 137 SLE pts shows that baseline IFN1 scores correl w/ Dz activity, # flares, prednisone doses, immunosuppressive use over 5 yrs https://t.co/OGb4NfrcIU

• https://bit.ly/3bOJAY0

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

• https://bit.ly/2LEm84M

New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5

• https://bit.ly/2N88WWp

QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY

• https://bit.ly/3bInlms

2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE

• https://bit.ly/3nMmd3x

Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/wzNmOzH4VE https://t.co/dgTTvRqESI

• https://bit.ly/3gE1Un3

ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM). https://t.co/HOB8CYn9yc https://t.co/AmT3AQdawa

• https://bit.ly/2LAYpm1

Real good historic review of RA drug development wherein Dr Paul Emery interviews Dr. Mike Weinblatt - Good Listen from the Cytokine Signaling Forum podcast https://t.co/R7rg7AwVlG

• https://bit.ly/3qmWjFd

QD Clinic - Stopping Meds https://t.co/zhtAHLeGqT https://t.co/rFmCch4WJ4

• https://bit.ly/39zqNgz